[PHAS] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[PHAS] PhaseBio Pharmaceuticals, Inc.
Announcement Date
14-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -26.59%
YoY- -38.33%
Quarter Report
PHAS's Result
PHAS's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 208 10,338 703 703 0 -
PBT -16,665 -27,079 -28,142 -9,232 -6,674 25.68%
Tax 116 1,600 -3,665 469 -1,120 -
NP -16,781 -28,679 -28,142 -9,232 -6,674 25.90%
Tax Rate - - - - - -
Total Cost 16,989 39,017 28,845 9,935 6,674 26.29%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -8,067.79 -277.41 -4,003.13 -1,313.23 0.00 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.34 -0.60 -0.98 -0.33 -0.34 0.00%
EPS Diluted -0.34 -0.60 -0.98 -0.33 -0.34 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.